|
Name |
(1R,2R,5R,8R,9S,10R,11R,12S)-12-hydroxy-11-methyl-6-methylidene-16-oxo-15-oxapentacyclo[9.3.2.15,8.01,10.02,8]heptadec-13-ene-9-carboxylate
|
| Molecular Formula | C19H21O5- | |
| IUPAC Name* |
(1R,2R,5R,8R,9S,10R,11R,12S)-12-hydroxy-11-methyl-6-methylidene-16-oxo-15-oxapentacyclo[9.3.2.15,8.01,10.02,8]heptadec-13-ene-9-carboxylate
|
|
| SMILES |
C[C@]12[C@H](C=C[C@@]3([C@@H]1[C@@H]([C@]45[C@H]3CC[C@H](C4)C(=C)C5)C(=O)[O-])OC2=O)O
|
|
| InChI |
InChI=1S/C19H22O5/c1-9-7-18-8-10(9)3-4-11(18)19-6-5-12(20)17(2,16(23)24-19)14(19)13(18)15(21)22/h5-6,10-14,20H,1,3-4,7-8H2,2H3,(H,21,22)/p-1/t10-,11-,12+,13-,14-,17+,18+,19-/m1/s1
|
|
| InChIKey |
SEEGHKWOBVVBTQ-UKJRIFTCSA-M
|
|
| Synonyms |
GA7
|
|
| CAS | NA | |
| PubChem CID | 25244338 | |
| ChEMBL ID | NA |
Chemical Classification: |
|
|
|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
|---|---|---|---|---|---|---|---|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
| Molecular Weight: | 329.4 | ALogp: | 2.3 |
| HBD: | 1 | HBA: | 5 |
| Rotatable Bonds: | 0 | Lipinski's rule of five: | Accepted |
| Polar Surface Area: | 86.7 | Aromatic Rings: | 5 |
| Heavy Atoms: | 24 | QED Weighted: | 0.572 |
| Caco-2 Permeability: | -5.58 | MDCK Permeability: | 0.00001550 |
| Pgp-inhibitor: | 0 | Pgp-substrate: | 0.082 |
| Human Intestinal Absorption (HIA): | 0.061 | 20% Bioavailability (F20%): | 0.522 |
| 30% Bioavailability (F30%): | 0.045 |
| Blood-Brain-Barrier Penetration (BBB): | 0.29 | Plasma Protein Binding (PPB): | 64.28% |
| Volume Distribution (VD): | 0.236 | Fu: | 27.62% |
| CYP1A2-inhibitor: | 0.005 | CYP1A2-substrate: | 0.235 |
| CYP2C19-inhibitor: | 0.011 | CYP2C19-substrate: | 0.418 |
| CYP2C9-inhibitor: | 0.007 | CYP2C9-substrate: | 0.168 |
| CYP2D6-inhibitor: | 0.006 | CYP2D6-substrate: | 0.14 |
| CYP3A4-inhibitor: | 0.123 | CYP3A4-substrate: | 0.084 |
| Clearance (CL): | 2.982 | Half-life (T1/2): | 0.826 |
| hERG Blockers: | 0.421 | Human Hepatotoxicity (H-HT): | 0.97 |
| Drug-inuced Liver Injury (DILI): | 0.787 | AMES Toxicity: | 0.008 |
| Rat Oral Acute Toxicity: | 0.965 | Maximum Recommended Daily Dose: | 0.98 |
| Skin Sensitization: | 0.251 | Carcinogencity: | 0.046 |
| Eye Corrosion: | 0.004 | Eye Irritation: | 0.025 |
| Respiratory Toxicity: | 0.961 |
| Similar NPs | Similar Drugs | ||||||
|---|---|---|---|---|---|---|---|
| NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
| ENC002558 | ![]() |
0.634 | D0CZ1Q | ![]() |
0.264 | ||
| ENC000143 | ![]() |
0.576 | D0D1SG | ![]() |
0.257 | ||
| ENC002555 | ![]() |
0.566 | D08PIQ | ![]() |
0.252 | ||
| ENC000794 | ![]() |
0.553 | D0D2TN | ![]() |
0.252 | ||
| ENC002556 | ![]() |
0.472 | D0V9DZ | ![]() |
0.252 | ||
| ENC002559 | ![]() |
0.457 | D06AEO | ![]() |
0.245 | ||
| ENC002542 | ![]() |
0.441 | D02JNM | ![]() |
0.244 | ||
| ENC002541 | ![]() |
0.375 | D0P0HT | ![]() |
0.243 | ||
| ENC003145 | ![]() |
0.271 | D04SFH | ![]() |
0.241 | ||
| ENC002850 | ![]() |
0.265 | D07DVK | ![]() |
0.237 | ||